Triple
T6005041
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Riluzole |
E133687
|
entity |
| Predicate | hasBrandName |
P40804
|
FINISHED |
| Object |
Teglutik
Teglutik is an oral liquid formulation of the drug riluzole used to slow disease progression in patients with amyotrophic lateral sclerosis (ALS).
|
E561110
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Teglutik | Statement: [Riluzole, hasBrandName, Teglutik]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Teglutik Context triple: [Riluzole, hasBrandName, Teglutik]
-
A.
Tektitek
Tektitek is a Mayan language spoken primarily by the Tektiteko people in parts of Guatemala and Mexico.
-
B.
Trikka
Trikka (also known as Trikala) is an ancient city in Thessaly, Greece, traditionally regarded as the birthplace and principal cult center of the healing god Asclepius.
-
C.
Tuktukan
Tuktukan is a barangay (village-level administrative division) in the city of Taguig in Metro Manila, Philippines.
-
D.
Tegsedi
Tegsedi is an antisense oligonucleotide drug used to treat hereditary transthyretin-mediated amyloidosis by reducing the production of the transthyretin protein.
-
E.
Tikkana
Tikkana was a prominent 13th-century Telugu poet and scholar best known for translating a major portion of the Mahabharata into Telugu and helping shape classical Telugu literature.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Teglutik Triple: [Riluzole, hasBrandName, Teglutik]
Generated description
Teglutik is an oral liquid formulation of the drug riluzole used to slow disease progression in patients with amyotrophic lateral sclerosis (ALS).
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Teglutik Target entity description: Teglutik is an oral liquid formulation of the drug riluzole used to slow disease progression in patients with amyotrophic lateral sclerosis (ALS).
-
A.
Tektitek
Tektitek is a Mayan language spoken primarily by the Tektiteko people in parts of Guatemala and Mexico.
-
B.
Trikka
Trikka (also known as Trikala) is an ancient city in Thessaly, Greece, traditionally regarded as the birthplace and principal cult center of the healing god Asclepius.
-
C.
Tuktukan
Tuktukan is a barangay (village-level administrative division) in the city of Taguig in Metro Manila, Philippines.
-
D.
Tegsedi
Tegsedi is an antisense oligonucleotide drug used to treat hereditary transthyretin-mediated amyloidosis by reducing the production of the transthyretin protein.
-
E.
Tikkana
Tikkana was a prominent 13th-century Telugu poet and scholar best known for translating a major portion of the Mahabharata into Telugu and helping shape classical Telugu literature.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00872444c8190bfaf1739dcec765c |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04f10d18081908c351170b7f58d3d |
completed | March 22, 2026, 8:20 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c1088f5c84819094e4696c24c4dd79 |
completed | March 23, 2026, 9:31 a.m. |
| NEDg | Description generation | batch_69c1099f00f88190a5f1f0fafbb679c2 |
completed | March 23, 2026, 9:36 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c10a2ffdcc8190bfeebc59d98b2b29 |
completed | March 23, 2026, 9:38 a.m. |
Created at: March 22, 2026, 4:06 p.m.